Sign Up to like & get recommendations! 1
Published in 2023 at "ChemBioChem"
DOI: 10.1002/cbic.202300077
Abstract: Antibody‐oligonucleotide conjugates (AOCs) are important tools for drug development and biochemical analysis. However, the structural heterogeneity of AOCs synthesized through conventional coupling methods raises reproducibility and safety concerns in clinical trials. To address these issues,… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-85352-w
Abstract: Antibody-Oligonucleotide Conjugates (AOCs) represent an emerging class of functionalized antibodies that have already been used in a wide variety of applications. While the impact of dye and drug conjugation on antibodies’ ability to bind their… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Chemical Science"
DOI: 10.1039/d1sc04937b
Abstract: A breadth of strategies are needed to efficiently modify oligonucleotides with peptides or lipids to capitalize on their therapeutic and diagnostic potential, including the modulation of in vivo chemical stability and for applications in cell-targeting… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Expert Opinion on Drug Delivery"
DOI: 10.1080/17425247.2018.1473375
Abstract: ABSTRACT Introduction: Oligonucleotide therapeutics have the potential to change the way disease is treated due to their ability to modulate gene expression of any therapeutic target in a highly specific and potent manner. Unfortunately, this… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Nucleic acids research"
DOI: 10.1093/nar/gkad415
Abstract: Although targeting TfR1 to deliver oligonucleotides to skeletal muscle has been demonstrated in rodents, effectiveness and pharmacokinetic/pharmacodynamic (PKPD) properties remained unknown in higher species. We developed antibody-oligonucleotide conjugates (AOCs) towards mice or monkeys utilizing anti-TfR1… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Applied Sciences"
DOI: 10.3390/app11031174
Abstract: New lipid conjugates of DNA and RNA incorporating one to four [(4-dodecylphenyl)sulfonyl]phosphoramidate or (hexadecylsulfonyl)phosphoramidate groups at internucleotidic positions near the 3′ or 5′-end were synthesized and characterized. Low cytotoxicity of the conjugates and their ability… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Biomolecules"
DOI: 10.3390/biom12101523
Abstract: Nucleic acids and proteins form two of the key classes of functional biomolecules. Through the ability to access specific protein-oligonucleotide conjugates, a broader range of functional molecules becomes accessible which leverages both the programmability and… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15010248
Abstract: Oligonucleotide conjugates are versatile scaffolds that can be applied in DNA-based screening platforms and ligand display or as therapeutics. Several different chemical approaches are available for functionalizing oligonucleotides, which are often carried out on the… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15020320
Abstract: Antisense and small interfering RNA (siRNA) oligonucleotides have been recognized as powerful therapeutic compounds for targeting mRNAs and inducing their degradation. However, a major obstacle is that unmodified oligonucleotides are not readily taken up into… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15061643
Abstract: Despite their clinical success, Antibody-Drug Conjugates (ADCs) are still limited to the delivery of a handful of cytotoxic small-molecule payloads. Adaptation of this successful format to the delivery of alternative types of cytotoxic payloads is… read more here.